The interim guidance [www.nice.org.uk/interimtonsillectomy guidance] was issued in response to a request from the Chief Medical Officers of England, Scotland and Northern Ireland to review urgently the use of diathermy tonsillectomy, and followed an interim analysis of the results of the National Prospective Tonsillectomy Audit which was carried out in England and Wales. The results 1 suggested that there was a higher risk of secondary haemorrhage requiring readmission to hospital and return to theatre after tonsillectomy using diathermy techniques or coblation compared with techniques which use no diathermy either for dissection or haemostasis.
This advice was issued in conjunction with an accompanying letter from Professor Richard Ramsden, Chairman of the Audit Steering Group, in which he summarized the results [www.nice.org.uk/pdf/ diathermytonsillectomyletterrichardramsden.pdf]. The interim guidance advised that all surgeons should consider how best to minimize their use of diathermy during tonsillectomy, particularly when diathermy is being used for both dissection and haemostasis. It highlighted that the risk may be particularly high for monopolar diathermy and surgeons should consider discontinuing this method. The risk may also be higher with currently available disposable diathermy equipment for tonsillectomy and again surgeons should consider discontinuing use of such equipment. In addition the Institute advised that the National Prospective Tonsillectomy Audit should continue and that all patients having tonsillectomy should be included.
In advising the Institute on this matter, the Interventional Procedures Advisory Committee were aware of the methodological challenges of assessing interim data, some of which have been raised by Mr Shahzad. The Institute will issue full guidance when a systematic review of the literature together with a more detailed analysis of the audit data is available.
In view of the concerns raised by the British Association of Otorhinolaryngologists, Head and Neck Surgeons' audit we consider that the Institute has taken a measured and appropriate approach to ensuring patient safety. 
